StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Reserve a call.

<< Previous

Bullboard Posts

Next >>

Post by IainCaimbeulon Mar 12, 2024 2:39pm

137 Views

Post# 35928944

Reserve a call.

Guess that has gone the way of Oncore. The Oncore "agreement" NR from 10 Oct 2019. Just wondering if the revenue cheques are rolling in yet?

Just setting the stage for 1 April 2024 YE/Q4 results so I won't be absolutely, completely, and utterly disappointed on that day. I plan to just absorb a bit of the punishment over the next of 8 trading days before Armaggedon